Search:

Johnson Mark's Articles in Legal Matters

  • How Reglan And Tardive Dyskinesia Are Linked
    There are substantial profits at stake in the pharmaceutical industry. Drug manufacturers that can produce medicines that relieve symptoms from a growing number of ailments stand to reap billions of dollars in revenues. With that as the backdrop, it is little wonder why manufacturers of the drug metoclopramide (the generic form of Reglan) have not taken adequate responsibility for the dangers of their product.
  • Reglan Manufacturers Avoid Multidistrict Litigation
    In May 2009, several Reglan lawyers filed a motion on behalf of their clients with the U.S. Judicial Panel on Multidistrict Litigation. The motion requested the consolidation of 15 pending Reglan lawsuits. That motion was denied in June. While the panel's decision escaped the notice of the popular media, it has significant meaning to those who are suffering the side effects of drugs containing metoclopramide.
  • Reglan and Tardive Dyskinesia Risk In Children
    Few things are as heartbreaking as the sight of young children suffering debilitating disorders. Worse still is the fact that many young people are afflicted with neurological side effects that were triggered by drugs once considered safe with few side effects. In some cases, kids are developing tardive dyskinesia, a repetitive movement disorder. The condition is brought about by the chronic use of metoclopramide drugs, including the branded version, Reglan.
  • Chronic Reglan Use And Side Effects
    In early 2009, the U.S. Food and Drug Administration (FDA) required that all manufacturers of metoclopramide products include a black box warning on their drug packaging. The reason for this mandate was the link between Reglan (brand name of metoclopramide) and tardive dyskinesia, a debilitating repetitive movement disorder. In truth, TD is only one of many potential side effects of long-term or high-dose use of the drug.

Powered by Article Dashboard